Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level652 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00512304 | Adjuvant Treatment of Gastric Cancer With Chemotherapy and Chemoradiotherapy (TRACE)(TRACE) | completed | Phase 2 | 63 | University Hospital, RouenOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT05411133 | Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients | completed | Phase 1 | 33 | Arbele Pty LtdINDUSTRY | 2 | Mar 19, 2026 | clinicaltrials |
| NCT03221426 | Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585) | completed | Phase 3 | 1,007 | Merck Sharp & Dohme LLCINDUSTRY | 24 | Mar 9, 2026 | clinicaltrials |
| NCT04882241 | Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension | completed | Phase 3 | 120 | Merck Sharp & Dohme LLCINDUSTRY | 1 | Mar 6, 2026 | clinicaltrials |
| NCT07453433 | Submucosal Pressure Ejection Endoscopic Dissection for Early Gastric Cancer: a Retrospective Cohort Study | completed | — | 548 | Shanghai East HospitalOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT06686966 | Prediction of Postoperative Complications and Survival in Gastric Cancer Using Preoperative Blood Markers | completed | — | 3,400 | First Affiliated Hospital of Chongqing Medical UniversityOTHER | 0 | Mar 3, 2026 | clinicaltrials |
| NCT03686488 | TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma | completed | Phase 2 | 23 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 2, 2026 | clinicaltrials |
| NCT07437573 | Oncometabolic Surgery(KLASS-09) | completed | Phase 3 | 94 | Korea University Guro HospitalOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT04426669 | A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering | completed | Phase 1 / Phase 2 | 23 | Intima Bioscience, Inc.INDUSTRY | 1 | Feb 23, 2026 | clinicaltrials |
| NCT07184047 | Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers(TOX-FRAIL) | completed | — | 72 | Ankara Etlik City HospitalOTHER_GOV | 1 | Feb 20, 2026 | clinicaltrials |
| NCT02248519 | Laparoscopic Versus Open Gastrectomy for Gastric Cancer(LOGICA) | completed | N/A | 210 | UMC UtrechtOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT04513223 | A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors | completed | Phase 1 | 101 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Feb 6, 2026 | clinicaltrials |
| NCT07387237 | Multigene Germline Panel Testing in Gastric Cancer Patients in Portugal | completed | — | 51 | Unidade Local De Saúde Do Norte AlentejanoOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT03008278 | Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery | completed | Phase 1 / Phase 2 | 51 | National Cancer Institute (NCI)NIH | 1 | Feb 3, 2026 | clinicaltrials |
| NCT04640480 | Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors | completed | Phase 1 | 21 | SN BioScienceINDUSTRY | 1 | Jan 27, 2026 | clinicaltrials |
| NCT05360680 | A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers | completed | Phase 1 | 42 | Cue BiopharmaINDUSTRY | 1 | Jan 22, 2026 | clinicaltrials |
| NCT05641896 | Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers(18F-FAPI-74 GI) | completed | Phase 2 | 109 | SOFIEINDUSTRY | 1 | Jan 22, 2026 | clinicaltrials |
| NCT04505553 | Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer | completed | Phase 2 | 78 | University of WashingtonOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07328633 | Prehabilitation Plus ERAS in Gastric Cancer Surgery | completed | N/A | 136 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT05898854 | [68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer | completed | Phase 2 | 20 | Aalborg University HospitalOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT03246516 | Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers(DELOGAST) | completed | N/A | 258 | University Hospital, LilleOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT05419362 | GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer | completed | Phase 2 | 42 | Genome & CompanyINDUSTRY | 1 | Dec 16, 2025 | clinicaltrials |
| NCT06981819 | Establishment and Effectiveness Evaluation of a Training System for Confocal Laser Endomicroscopy | completed | — | 147 | Changhai HospitalOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT06549816 | A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors | completed | Phase 1 | 6 | Seagen, a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 15, 2025 | clinicaltrials |
| NCT04157985 | Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors | completed | Phase 3 | 161 | Dan ZandbergOTHER | 1 | Dec 11, 2025 | clinicaltrials |
| NCT04798781 | Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma | completed | Phase 2 | 16 | Andrew Hendifar, MDOTHER | 1 | Dec 11, 2025 | clinicaltrials |
| NCT06452329 | A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction Cancer | completed | — | 260 | Bristol-Myers SquibbINDUSTRY | 1 | Dec 4, 2025 | clinicaltrials |
| NCT03223376 | A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA)(FRUTIGA) | completed | Phase 3 | 703 | Hutchison Medipharma LimitedINDUSTRY | 1 | Dec 1, 2025 | clinicaltrials |
| NCT07155330 | High-flow Nasal Cannula Oxygenation in Sedated Endoscopy for High-risk Obstructive Sleep Apnea Patients | completed | N/A | 80 | Zhejiang UniversityOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT07243847 | Recurrence and Prognosis Prediction Model for Gastric Cancer | completed | — | 5,000 | Fudan UniversityOTHER | 0 | Nov 24, 2025 | clinicaltrials |
| NCT07244471 | Water-injecting Endoscopic Submucosal Dissection for Early Gastric Cancer: a Retrospective Cohort Study | completed | — | 548 | Shanghai East HospitalOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05472532 | Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture)(INOVOLINE) | completed | N/A | 101 | Hospices Civils de LyonOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT06023966 | A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative Surgery | completed | — | 120 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT06614439 | PG Versus TG for Advanced PGC | completed | N/A | 96 | National Taiwan University HospitalOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT01191697 | CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer | completed | Phase 2 | 37 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 3, 2025 | clinicaltrials |
| NCT03620643 | Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours(ROLo) | completed | Phase 2 | 33 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 30, 2025 | clinicaltrials |
| NCT04208958 | Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer(ConsortiumIO) | completed | Phase 1 / Phase 2 | 56 | Vedanta Biosciences, Inc.INDUSTRY | 1 | Oct 27, 2025 | clinicaltrials |
| NCT03819088 | Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer | completed | N/A | 17 | Emory UniversityOTHER | 1 | Oct 9, 2025 | clinicaltrials |
| NCT07211880 | Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based Study | completed | N/A | 1,043 | Zero Helicobacter IGAN NetworkOTHER | 1 | Oct 8, 2025 | clinicaltrials |
| NCT07213115 | Epidemiology and Treatment of Gastric Cancer | completed | — | 8,582 | Medizinische Hochschule Brandenburg Theodor FontaneOTHER | 0 | Oct 8, 2025 | clinicaltrials |
| NCT04526886 | Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy | completed | N/A | 52 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT02738294 | Necessity Assessment of ME-NBI Targeted Biopsy Compared With EFB | completed | N/A | 211 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT04768686 | FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer | completed | Phase 2 | 20 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | Sep 25, 2025 | clinicaltrials |
| NCT05644249 | PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer | completed | N/A | 37 | Vilnius UniversityOTHER | 1 | Sep 24, 2025 | clinicaltrials |
| NCT07190040 | Integrating Multi-Omics Data for Enhanced Prognosis Prediction in Gastric Cancer Post-Neoadjuvant Therapy | completed | — | 179 | Chang-Ming Huang, Prof.OTHER | 1 | Sep 24, 2025 | clinicaltrials |
| NCT06339307 | A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC Patients | completed | — | 120 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT07177560 | Topical Diclofenac for Hand-Foot Syndrome Prevention in Colorectal and Gastric Cancer on Capecitabine (DICLO-HFS)(DICLO-HFS) | completed | — | 151 | Gazi UniversityOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT04344795 | Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors | completed | Phase 1 | 89 | Tempest TherapeuticsINDUSTRY | 1 | Sep 12, 2025 | clinicaltrials |
Data updated 22 days agoSource updated Mar 27, 2026source: clinicaltrials